In a recent report, the authors identified high mobility group protein B2 (HMGB2), which plays a crucial role in the metastasis and growth of HCC, as a novel NAT10-mediated downstream effector of ac4C through RNA-seq and ribo-seq analyses [20]. Here, NAT10 is linked to hepatocellular carcinoma.